Immunoglobulins

"Immunoglobulins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

expand / collapse MeSH information
Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses.


expand / collapse Publications
This graph shows the total number of publications written about "Immunoglobulins" by people in this website by year, and whether "Immunoglobulins" was a major or minor topic of these publications.
Below are the most recent publications written about "Immunoglobulins" by people in Profiles.
  1. Immunoglobulins act as predictors of chronicity in pediatric immune thrombocytopenia. Blood Adv. 2024 10 08; 8(19):5118-5121.
    View in: PubMed
  2. Long-Term Safety of Facilitated Subcutaneous Immunoglobulin 10% Treatment in US Clinical Practice in Patients with Primary Immunodeficiency Diseases: Results from a Post-Authorization Safety Study. J Clin Immunol. 2024 08 19; 44(8):181.
    View in: PubMed
  3. Tolerability and Safety of Large-Volume Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% Administered with or without Dose Ramp-Up: A Phase 1 Study in Healthy Participants. J Clin Immunol. 2024 06 19; 44(7):148.
    View in: PubMed
  4. Long-term safety of hyaluronidase-facilitated subcutaneous immunoglobulin 10%: a European post-authorization study. Immunotherapy. 2024; 16(10):679-691.
    View in: PubMed
  5. Plasma viscosity, immunoglobulins and risk of cardiovascular disease and mortality: new data and meta-analyses. J Clin Pathol. 2024 May 17; 77(6):394-401.
    View in: PubMed
  6. Selective Targeting of α4β7/MAdCAM-1 Axis Suppresses Fibrosis Progression by Reducing Proinflammatory T Cell Recruitment to the Liver. Cells. 2024 04 27; 13(9).
    View in: PubMed
  7. Specificity of immunoglobulin high-throughput sequencing minimal residual disease monitoring in non-Hodgkin lymphomas. Blood Adv. 2024 02 13; 8(3):780-784.
    View in: PubMed
  8. Translating B cell immunology to the treatment of antibody-mediated allograft rejection. Nat Rev Nephrol. 2024 04; 20(4):218-232.
    View in: PubMed
  9. Low frequency of HBsAg reemergence in liver transplant recipients after stopping hepatitis B immune globulin: Implications for prophylaxis protocols. Liver Transpl. 2024 Jun 01; 30(6):668-671.
    View in: PubMed
  10. Immunoglobulin superfamily member 3 is required for the vagal neural crest cell migration and enteric neuronal network organization. Sci Rep. 2023 10 11; 13(1):17162.
    View in: PubMed